Skip to main content
. 2013 Apr 19;73(6):1071–1078. doi: 10.1136/annrheumdis-2012-202818

Figure 1.

Figure 1

Treatment protocol COBRA-light study. *Methotrexate must first be increased to 25 mg/week. DAS44, 44-joint disease activity score; MTX, methotrexate; sc, subcutaneous; TNF, tumour necrosis factor.